This study will be the first systematic neuropharmacological approach to the monoaminergic system in dementia. The primary goal of this project is to determine the dependence upon monoaminergic systems of specific cognitive abilities and mood in patients with Alzheimer's disease. Accordingly, in separate protocols, we will examine the effects of administering single drugs that increase and decrease noradrenergic turnover; the drugs are yohimbine and clonidine respectively. A related goal of this project is to improve cognitive capacities in patients with Alzheimer's disease by administering drugs that alter monoaminergic neurotransmission. Although the cholinergic hypothesis of memory dysfunction in Alzheimer's disease remains compelling, the finding of multiple neurotransmitter deficits in the Alzheimer's disease brain militates against the success of simple cholinergic replacement therapy. We therefore propose to extend our current studies with cholinergic drugs by combining lecithin (phosphatidylcholine, or PC) with clonidine or yohimbine and, in a separate protocol, PC with tryptophan (TRY), a drug that increases the synthesis and release of serotonin (5-HT). Patients with Alzheimer's disease will be selected according to strict inclusion and exclusion criteria. The protocols call for measurements of neurological signs, psychiatric state, neuropsychological test performance, and neurotransmitter markers in plasma and cerebrospinal fluid (CSF). Special emphasis will be placed upon the development and implementation of new tests that improve the characterization of specific cognitive deficits in Alzheimer's disease, and on the use of these tests as measures of change induced by drugs. Tests of forgetting, attentional focusing, and praxis will be highlighted. The results of this research will provide new information regarding the biochemical substrates of cognition.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH032724-08
Application #
3375371
Study Section
(TDAB)
Project Start
1980-02-01
Project End
1988-01-31
Budget Start
1987-03-01
Budget End
1988-01-31
Support Year
8
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
Schools of Arts and Sciences
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Sullivan, E V; Sagar, H J (1991) Double dissociation of short-term and long-term memory for nonverbal material in Parkinson's disease and global amnesia. A further analysis. Brain 114 ( Pt 2):893-906
Sagar, H J; Gabrieli, J D; Sullivan, E V et al. (1990) Recency and frequency discrimination in the amnesic patient H.M. Brain 113 ( Pt 3):581-602
Sullivan, E V; Sagar, H J; Gabrieli, J D et al. (1989) Different cognitive profiles on standard behavioral tests in Parkinson's disease and Alzheimer's disease. J Clin Exp Neuropsychol 11:799-820
Sullivan, E V (1989) Hemispheric asymmetry in tactile forgetting induced by tactually-guided movement. Cortex 25:83-92
Sullivan, E V; Sagar, H J (1989) Nonverbal recognition and recency discrimination deficits in Parkinson's disease and Alzheimer's disease. Brain 112 ( Pt 6):1503-17
Sagar, H J; Sullivan, E V; Gabrieli, J D et al. (1988) Temporal ordering and short-term memory deficits in Parkinson's disease. Brain 111 ( Pt 3):525-39
Freed, D M; Kandel, E (1988) Long-term occupational exposure and the diagnosis of dementia. Neurotoxicology 9:391-400
Sagar, H J; Cohen, N J; Sullivan, E V et al. (1988) Remote memory function in Alzheimer's disease and Parkinson's disease. Brain 111 ( Pt 1):185-206
Huff, F J; Growdon, J H; Corkin, S et al. (1987) Age at onset and rate of progression of Alzheimer's disease. J Am Geriatr Soc 35:27-30
Rosen, T J; Growdon, J H; Corkin, S (1987) Comparison of rates of progression in Alzheimer's disease and Parkinson's disease. J Neural Transm Suppl 24:105-7

Showing the most recent 10 out of 19 publications